British drugmaker GlaxoSmithKline PLC (GSK) yesterday spun off its consumer health business in the biggest listing in Europe in more than a decade.
The new company, Haleon, becomes the world’s biggest standalone consumer health business, home to brands including Sensodyne toothpaste and Advil painkillers.
Shares in Haleon started trading at ￡3.30 yesterday morning, giving the business a market valuation of about ￡30.5 billion (US$36.4 billion), according to Reuters calculations.
File photo: Reuters
HIGH HOPES
There were high hopes for Haleon’s market valuation after GSK in January said it had rebuffed a ￡50 billion offer from Unilever PLC on the basis it was too low.
Excluding floats carried out via the Shanghai London Stock Connect, Haleon’s listing is the largest on the London Stock Exchange since Glencore listed in May 2011 with a market cap of about ￡37 billion, according to Refinitiv data.
GSK emerges as New GSK, focused solely on vaccines and prescription drugs. The business has been buoyed by recent clinical trial successes, including its potential blockbuster RSV vaccine, and merger and acquisition activity.
There is also the opportunity to use part of the ￡7 billion of financial firepower it would generate through the Haleon spin-off to fund more deals.
DOWNTURN
However, GSK has underperformed relative to its peers in recent years, triggered by a falling share of research and development spending, a series of oncology clinical failures, and missing out on the lucrative market for the first set of COVID-19 vaccines, despite being one of the world’s major vaccine makers.
With the split complete, all GSK shareholders receive one Haleon share for each GSK share they own.
Pfizer Inc would retain its 32 percent stake in Haleon, which it intends on selling off over time. GSK would hold up to 13.5 percent in Haleon, while the remaining 54.5 percent would be owned by GSK shareholders.
After close of trading yesterday, GSK would consolidate its share price, returning it to roughly the same as before the demerger.
That would ensure the company’s earnings per share and share price can be compared with previous periods, it has said.
Taiwanese suppliers to Taiwan Semiconductor Manufacturing Co. (TSMC, 台積電) are expected to follow the contract chipmaker’s step to invest in the US, but their relocation may be seven to eight years away, Minister of Economic Affairs J.W. Kuo (郭智輝) said yesterday. When asked by opposition Chinese Nationalist Party (KMT) Legislator Niu Hsu-ting (牛煦庭) in the legislature about growing concerns that TSMC’s huge investments in the US will prompt its suppliers to follow suit, Kuo said based on the chipmaker’s current limited production volume, it is unlikely to lead its supply chain to go there for now. “Unless TSMC completes its planned six
Intel Corp has named Tasha Chuang (莊蓓瑜) to lead Intel Taiwan in a bid to reinforce relations between the company and its Taiwanese partners. The appointment of Chuang as general manager for Intel Taiwan takes effect on Thursday, the firm said in a statement yesterday. Chuang is to lead her team in Taiwan to pursue product development and sales growth in an effort to reinforce the company’s ties with its partners and clients, Intel said. Chuang was previously in charge of managing Intel’s ties with leading Taiwanese PC brand Asustek Computer Inc (華碩), which included helping Asustek strengthen its global businesses, the company
Power supply and electronic components maker Delta Electronics Inc (台達電) yesterday said second-quarter revenue is expected to surpass the first quarter, which rose 30 percent year-on-year to NT$118.92 billion (US$3.71 billion). Revenue this quarter is likely to grow, as US clients have front-loaded orders ahead of US President Donald Trump’s planned tariffs on Taiwanese goods, Delta chairman Ping Cheng (鄭平) said at an earnings conference in Taipei, referring to the 90-day pause in tariff implementation Trump announced on April 9. While situations in the third and fourth quarters remain unclear, “We will not halt our long-term deployments and do not plan to
The New Taiwan dollar and Taiwanese stocks surged on signs that trade tensions between the world’s top two economies might start easing and as US tech earnings boosted the outlook of the nation’s semiconductor exports. The NT dollar strengthened as much as 3.8 percent versus the US dollar to 30.815, the biggest intraday gain since January 2011, closing at NT$31.064. The benchmark TAIEX jumped 2.73 percent to outperform the region’s equity gauges. Outlook for global trade improved after China said it is assessing possible trade talks with the US, providing a boost for the nation’s currency and shares. As the NT dollar
RSS